Join
Live feed
·
INSIDERFilingvia Quantisnow
Aldeyra Therapeutics Inc. logo

Chief Development Officer Machatha Stephen sold $75,975 worth of shares (16,041 units at $4.74), decreasing direct ownership by 6% to 236,771 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ALDX· Aldeyra Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALDX (Aldeyra Therapeutics Inc.) and more on Quantisnow.